Rhythm Pharmaceuticals

About Rhythm Pharmaceuticals

Rhythm Pharmaceuticals is a global biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by advancing care and developing precision medicines that address the root cause. They are committed to supporting patients, families, and healthcare providers.

Products & Services

MC4R Agonists (Setmelanotide and Bivamelagon):Treatments targeting rare neuroendocrine diseases, focusing on conditions like hyperphagia and obesity.

Pipeline Treatments:A portfolio of treatment options under development for patients with hyperphagia and obesity to ensure tailored care.

Specialties

Rare Neuroendocrine Diseases Precision Medicines MC4R Pathway Treatments Hyperphagia and Obesity Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 175000000 MR: - FA: approximately $175 million FAN: 175000000	D: 2025-07-10 FD: 2025-07-10	6 investors
2	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: 150 million FAN: 150000000	D: 2025-07-09 FD: 2025-07-09	6 investors
3	RT: Convertible Preferred Stock T: - FT: Convertible Preferred Stock	A: 150000000 MR: - FA: 150 million FAN: 150000000	D: 2024-04-01 FD: 2024-04-01	3 investors

Public Offering Latest

2025-07-10

$175.0M

6 investors (Pro only)

Public Offering 2025-07-09

$150.0M

Convertible Preferred Stock 2024-04-01

$150.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Meeker

Chairman, President, and Chief Executive Officer

J

Jennifer Lee

Executive Vice President, Head of North America

Y

Yann Mazabraud

Executive Vice President, Head of International

H

Hunter Smith

Chief Financial Officer

J

Joe Shulman

Chief Technical Officer

A

Alastair Garfield

Chief Scientific Officer

View 18 more team members with Pro

Unlock Full Team Directory

Recent News